This methylation enhances the interaction of FOXO1 with S-phase kinase-associated protein 2 (SKP2), an E3 ubiquitin ligase, resulting in the degradation of FOXO1 and increasing colon cancer cell proliferation [101]. Here, SKP2 is linked to malignant colon neoplasm.